The interplay of the two factors was also further suggested by the fact that the growth-promoting impact of the COLα1 (I) on pancreatic cancer cells could be inhibited following the addition of DDR1 inhibitors or in the presence of cleavage-resistant COLα1 (I). The gene discussed is DDR1; the disease is pancreatic neoplasm.